Telix Pharmaceuticals Ltd banner

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 9.17 AUD -5.95% Market Closed
Market Cap: AU$3.1B

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 25.02 AUD with a low forecast of 17.17 AUD and a high forecast of 35.7 AUD.

Lowest
Price Target
17.17 AUD
87% Upside
Average
Price Target
25.02 AUD
173% Upside
Highest
Price Target
35.7 AUD
289% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
QLYS
Qualys Inc
39% Upside
SDGR
Schrodinger Inc
122% Upside
GOSS
Gossamer Bio Inc
307% Upside
ITRN
Ituran Location and Control Ltd
9% Upside

Revenue
Forecast

271% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
271% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 271%. The projected CAGR for the next 4 years is 27%.

Operating Income
Forecast

N/A
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
54%
Average Beat
N/A
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
54%
Average Beat

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 4 years is 52%.

Net Income
Forecast

N/A
Past Growth
56% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
56% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 4 years is 56%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
25.02 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 25.02 AUD with a low forecast of 17.17 AUD and a high forecast of 35.7 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
27%

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 271%. The projected CAGR for the next 4 years is 27%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
52%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 4 years is 52%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
56%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 4 years is 56%.

Back to Top